Making Innovative Drugs Available Globally

In order to bring innovative biopharmaceutical to the global market companies must navigate the unique regulations of each country they seek to enter. This enormous regulatory hurdle delays access to the newest innovations and is a primary reason patients in the U.S. often have access to life saving therapies years before they are available anywhere else.
Lila Feisee BIO’s Vice President International Affairs addresses this issue and the International Council on Harmonization’s&